-
Published09/01/2025
-
Deadline10/02/2025
-
Today18/02/2025
Utilities
- indicates text translated automatically in your browsing language
Medicinal products with the active substance HUMAN INHIBITOR ALFA1-PROTEINASY Text automatically translated in your browsing language Automatically translated
The subject of the procurement procedure is the conclusion of a framework purchase contract for the supply of medicinal products according to the needs of the contracting authority. Text automatically translated in your browsing language Automatically translated
https://ezak.fnbrno.cz/
https://ezak.fnbrno.cz/
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.